Jones Financial Companies Lllp Buys 12,758 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Jones Financial Companies Lllp boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 61.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,386 shares of the company's stock after purchasing an additional 12,758 shares during the quarter. Jones Financial Companies Lllp's holdings in GE HealthCare Technologies were worth $2,610,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of GEHC. Cherry Creek Investment Advisors Inc. raised its position in shares of GE HealthCare Technologies by 0.3% during the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock valued at $2,920,000 after buying an additional 114 shares in the last quarter. Independence Bank of Kentucky raised its position in shares of GE HealthCare Technologies by 6.0% during the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock valued at $158,000 after buying an additional 114 shares in the last quarter. Tandem Capital Management Corp ADV raised its position in shares of GE HealthCare Technologies by 0.4% during the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock valued at $2,205,000 after buying an additional 118 shares in the last quarter. Arcus Capital Partners LLC raised its position in shares of GE HealthCare Technologies by 3.0% during the 4th quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock valued at $322,000 after buying an additional 119 shares in the last quarter. Finally, Custom Index Systems LLC raised its position in shares of GE HealthCare Technologies by 4.4% during the 4th quarter. Custom Index Systems LLC now owns 2,843 shares of the company's stock valued at $222,000 after buying an additional 120 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analyst Weigh In

Several analysts have recently weighed in on GEHC shares. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $97.67.

GE HealthCare Technologies Trading Up 1.4 %

GE HealthCare Technologies stock traded up $1.17 during trading hours on Friday, reaching $86.58. The stock had a trading volume of 4,075,712 shares, compared to its average volume of 2,984,066. The stock has a market cap of $39.59 billion, a PE ratio of 20.00, a PEG ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a fifty day simple moving average of $86.77 and a 200-day simple moving average of $86.15.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.